Tousignant Jennifer's Form 4 filing
Viridian Therapeutics, Inc. (VRDN) · filed Jan 2, 2026
- Accession no.
- 0001193125-26-001097
- Filed
- Jan 2, 2026
- Trade date
- Dec 31, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $70.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tousignant JenniferCIK 0002010978 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | Common Stock | SSaleDisposed | −2,272 | $31.16 | −$70,795.52 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.